Proacta S.A. logo

Proacta S.A. (WS3)

Market Closed
16 Oct, 08:00 PM
XFRA XFRA
€
0. 25
-0.02
-5.9259%
€
31.24M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
€ 0.27
Previous Close
Add Transaction
Day Range
0.25 0.26
Year Range
0.2 0.36
Want to track WS3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

WS3 closed today lower at €0.25, a decrease of -5.9259% from yesterday's close, completing a monthly decrease of -4.5113% or -€0.01. Over the past 12 months, WS3 stock lost -13.0137%.
WS3 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

WS3 Chart

Proacta S.A. (WS3) FAQ

What is the stock price today?

The current price is €0.25.

On which exchange is it traded?

Proacta S.A. is listed on XFRA.

What is its stock symbol?

The ticker symbol is WS3.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 31.24M.

Has Proacta S.A. ever had a stock split?

No, there has never been a stock split.

Proacta S.A. Profile

- Industry
- Sector
Mr. Pawel Ciesielka CEO
XFRA Exchange
- ISIN
Poland Country
15 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Proacta S.A. is a renowned Polish technology firm that concentrates on innovative software development, bioinformatics, and healthcare solutions leveraging artificial intelligence. The organization is dedicated to creating advanced medical and analytical platforms which aid in the interpretation of laboratory results, patient monitoring, and the integration of medical and genetic data into clinical workflows. With its headquarters in Warsaw, Proacta S.A. occupies a pivotal position at the intersection of healthcare, data science, and enterprise software within the Polish technology landscape. Additionally, the company collaborates with public institutions and private-sector clients, working diligently to deliver bespoke technology projects designed to meet specific operational demands.

Products and Services

  • Digital Diagnostics Solutions:

    These solutions aim to enhance the accuracy and speed of medical diagnostics through digital means, facilitating better patient outcomes by leveraging technological advancements in data interpretation and analysis.

  • Oncology Support Platforms:

    Proacta offers specialized platforms that support oncologists in decision-making processes, providing critical insights based on medical and genetic data to optimize patient treatment plans.

  • Health-Data Management Solutions:

    The company provides robust systems that ensure efficient management, storage, and analysis of health data, improving access to vital information for healthcare providers while ensuring regulatory compliance and security.

  • Custom IT Services:

    Proacta S.A. excels in delivering tailored IT services, including the development of custom web and mobile applications that address unique client needs while leveraging state-of-the-art technologies, ensuring adaptability and scalability.

  • AI/ML Development:

    With a focus on artificial intelligence and machine learning, Proacta develops intelligible algorithms that can analyze vast amounts of data, supporting predictive analytics and enhancing decision-making in healthcare.

  • Cloud Services:

    The company offers comprehensive cloud-based solutions designed to enhance data accessibility and collaboration, allowing healthcare professionals to manage information more efficiently and securely.

  • System Integration:

    Proacta ensures seamless integration of newly developed systems with existing infrastructures, facilitating interoperability between various software and hardware platforms, which enhances overall operational efficiency for healthcare providers.

Contact Information

Address: ul. Srebrna 16
Phone: 48 22 699 7132